Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment Costs and Patterns In Patients With Multiple Sclerosis Treated With Prolonged-Release Fampridine In Germany.
Transplantation of mesenchymal stem cells in a laryngeal carcinoma patient with radiation myelitis.
The Significance of Matrix Metalloproteinases in the Immunopathogenesis and Treatment of Multiple Sclerosis.
Characteristics of demyelinating Charcot-Marie-Tooth disease with concurrent diabetes mellitus.
Misfiring in multiple sclerosis: Cerebellar Channelopathy, a Potential Novel Target?
Lotensin: Cheap 180
CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable?
Understanding fatigue in paediatric multiple sclerosis: a systematic review of clinical and psychosocial factors.
Multiple Sclerosis Associated Risk Factors: A Case-Control Study.
No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy.
The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis.
Neuroinflammation: A common denominator for stroke, multiple sclerosis and Alzheimer's disease.
Deletion of jun proteins in adult oligodendrocytes does not perturb cell survival, or myelin maintenance in vivo.
Personality factors in recently diagnosed multiple sclerosis patients: a preliminary investigation with the NEO-FFI scale.
Preclinical Models of Multiple Sclerosis: Advantages and Limitations towards Better Therapies.
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study.
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.
MicroRNAs as Novel Regulators of Neuroinflammation.
Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed.
Relationship Between Regional Atherosclerosis and Adjacent Spinal Cord Histology.
Increased serum levels of C21 steroids in female patients with multiple sclerosis.
Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes.
Hilbert-Huang transform based instrumental assessment of intention tremor in multiple sclerosis.
HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation.
Pages
« first
‹ previous
…
706
707
708
709
710
711
712
713
714
…
next ›
last »